Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 898931, 6 pages
Review Article

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?

1University Department of Medicine, Queen Mary Hospital, Hong Kong
2University Department of Surgery, Queen Mary Hospital, New Clinical Building, 102 Pokfulam Road, Room 211B, Hong Kong
3Centre for Cancer Research, The University of Hong Kong, Hong Kong

Received 7 July 2012; Accepted 2 November 2012

Academic Editor: Marcus Bahra

Copyright © 2012 Joanne Chiu and Thomas Yau. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Asmaa E El-Kenawi, and Azza B El-Remessy, “Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales,” British Journal of Pharmacology, vol. 170, no. 4, pp. 712–729, 2013. View at Publisher · View at Google Scholar
  • Yi-Ting Tang, Xiao-Hui Xu, Xiao-Dong Yang, Jun Hao, Han Cao, Wei Zhu, Shu-Yu Zhang, and Jian-Ping Cao, “Role of non-coding RNAs in pancreatic cancer: The bane of the microworld,” World Journal of Gastroenterology, vol. 20, no. 28, pp. 9405–9417, 2014. View at Publisher · View at Google Scholar
  • Jun Yu, and Qi Chen, “Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer,” Integrative Cancer Therapies, vol. 13, no. 3, pp. 217–225, 2014. View at Publisher · View at Google Scholar
  • Akira Umemura, Hiroyuki Nitta, Akira Sasaki, Takeshi Takahara, Yasushi Hasegawa, and Go Wakabayashi, “Modified FOLFIRINOX for Locally Advanced and Metastatic Pancreatic Cancer Patients Resistant to Gemcitabine and S-1 in Japan: A Single Institutional E,” Hepato-Gastroenterology, vol. 61, no. 131, pp. 814–820, 2014. View at Publisher · View at Google Scholar
  • Siliang Wang, Xiaodong Chen, and Meiyue Tang, “MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2,” Oncology Reports, vol. 32, no. 6, pp. 2824–2830, 2014. View at Publisher · View at Google Scholar
  • Kripa Patel, Anita Kollory, Asami Takashima, Sibaji Sarkar, Douglas V. Faller, and Sajal K. Ghosh, “MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression,” Cancer Letters, 2014. View at Publisher · View at Google Scholar
  • Han, Zhuo, Cui, Hu, Wang, Jiao, and Wang, “Long non-coding RNA: An emerging paradigm of pancreatic cancer,” Current Molecular Medicine, vol. 16, no. 8, pp. 702–709, 2016. View at Publisher · View at Google Scholar